1. Home
  2. IMXI vs CRGX Comparison

IMXI vs CRGX Comparison

Compare IMXI & CRGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMXI
  • CRGX
  • Stock Information
  • Founded
  • IMXI 1994
  • CRGX 2021
  • Country
  • IMXI United States
  • CRGX United States
  • Employees
  • IMXI N/A
  • CRGX N/A
  • Industry
  • IMXI Retail: Computer Software & Peripheral Equipment
  • CRGX
  • Sector
  • IMXI Technology
  • CRGX
  • Exchange
  • IMXI Nasdaq
  • CRGX Nasdaq
  • Market Cap
  • IMXI 302.5M
  • CRGX 190.0M
  • IPO Year
  • IMXI N/A
  • CRGX 2023
  • Fundamental
  • Price
  • IMXI $10.30
  • CRGX $4.59
  • Analyst Decision
  • IMXI Buy
  • CRGX Hold
  • Analyst Count
  • IMXI 7
  • CRGX 7
  • Target Price
  • IMXI $19.60
  • CRGX $5.33
  • AVG Volume (30 Days)
  • IMXI 318.6K
  • CRGX 1.9M
  • Earning Date
  • IMXI 08-06-2025
  • CRGX 08-11-2025
  • Dividend Yield
  • IMXI N/A
  • CRGX N/A
  • EPS Growth
  • IMXI 1.60
  • CRGX N/A
  • EPS
  • IMXI 1.70
  • CRGX N/A
  • Revenue
  • IMXI $652,547,000.00
  • CRGX N/A
  • Revenue This Year
  • IMXI N/A
  • CRGX $57.81
  • Revenue Next Year
  • IMXI $3.03
  • CRGX N/A
  • P/E Ratio
  • IMXI $6.02
  • CRGX N/A
  • Revenue Growth
  • IMXI N/A
  • CRGX N/A
  • 52 Week Low
  • IMXI $9.76
  • CRGX $3.00
  • 52 Week High
  • IMXI $22.38
  • CRGX $25.45
  • Technical
  • Relative Strength Index (RSI)
  • IMXI 45.01
  • CRGX 61.56
  • Support Level
  • IMXI $10.22
  • CRGX $4.32
  • Resistance Level
  • IMXI $10.87
  • CRGX $4.63
  • Average True Range (ATR)
  • IMXI 0.34
  • CRGX 0.16
  • MACD
  • IMXI 0.05
  • CRGX 0.04
  • Stochastic Oscillator
  • IMXI 48.65
  • CRGX 76.44

About IMXI International Money Express Inc.

International Money Express Inc is a processor of money transfer services in the USA to the Latin America and the Caribbean (LAC) corridor. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.

About CRGX CARGO Therapeutics Inc.

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platforms, and manufacturing are designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. Its product includes CRG-023, an investigational tri-specific CAR T designed to address several known causes of relapse associated with existing CAR T-cell therapies such as loss of tumor antigen expression, loss of co-stimulation (e.g., via CD58/CD2 signaling) and T cell exhaustion. CRG-023 is designed to target the B-cell lineage antigens (CD19, CD20, CD22) via tri-cistronic expression of three distinct CARs from a single lentiviral vector.

Share on Social Networks: